CONSORT 2025 Flow Diagram [70]. by Robert Trybulski (10998702)

Subjects:

Fer-1 increased SLC7A11 and Nrf2 expression to resist <i>C. sinensis</i>-induced ferroptosis. by Haoyang Zhang (1706815)

Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

Subjects:

The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

Subjects:

Relative abundance of bacteria phyla (a) and classes (b) in root zone soil of different tea varieties. by Jun Sun (48981)

Subjects:

Properties of differential lipids that have increased and decreased abundance in the BmNPV-infected group of head samples at 96 hpi. by Min Feng (141118)

The interaction effect of urinary bisphenol A exposure levels at two time points during childhood on serum thyroid hormone concentrations in adolescence. by Jung Eun Choi (563339)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Pretreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction. by Lijuan Liu (136685)

Subjects:

Cephalometric measurement points. by Lijuan Liu (136685)

Subjects:

Relative Index of Inequality (RII) and 95% Confidence Interval (CI) for access question between most a least deprived SIMD decile by A) Age and sex B) Number of Health Issues and c... by David Henderson (4612354)

Subjects: